We can help you find what you need. Get in touch with us.
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth Summary GBI Research, the leading business intelligence provider, has released its latest report, Biomarkers in Cancer Research - High Unmet Need....
Biomaterials | Sep 28th, 2010 | by GBI Research
Industry : Healthcare
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars....
Biomaterials | Apr 01st, 2011 | by GBI Research
Industry : Healthcare
Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production Summary GBI Research, the leading business intelligence provider, has....
Biomaterials | Jun 25th, 2012 | by GBI Research
Industry : Healthcare
Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth Summary GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars i....
Biomaterials | Jul 10th, 2012 | by GBI Research
Industry : Healthcare
About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of th....
Biomaterials | Nov 19th, 2014 | by Technavio
Industry : Healthcare